156 related articles for article (PubMed ID: 32234089)
21. In Vivo Treatment with the Combination of Nitazoxanide and Flubendazole Induces Gluconeogenesis and Protein Catabolism in Taenia crassiceps cysticerci.
Lima NF; Picanço GA; Costa TL; de Souza Lino Junior R; Vinaud MC
Acta Parasitol; 2021 Mar; 66(1):98-103. PubMed ID: 32761323
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the efficacy of albendazole sulphoxide and praziquantel in combination on Taenia crassiceps cysts: in vitro studies.
Palomares F; Palencia G; Ambrosio JR; Ortiz A; Jung-Cook H
J Antimicrob Chemother; 2006 Mar; 57(3):482-8. PubMed ID: 16410266
[TBL] [Abstract][Full Text] [Related]
23. Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies.
Francisca PA; Javier LF; Guadalupe PH; Fernanda GM; Nelly C; Helgi JC; Iliana GH; Susana RI
Acta Trop; 2020 Feb; 202():105238. PubMed ID: 31669532
[TBL] [Abstract][Full Text] [Related]
24. Adhesion molecules, chemokines and matrix metallo-proteinases response after albendazole and albendazole plus steroid therapy in swine neurocysticercosis.
Singh SK; Prasad KN; Singh AK; Gupta KK; Singh A; Tripathi M; Gupta RK
Exp Parasitol; 2017 Nov; 182():1-8. PubMed ID: 28821422
[TBL] [Abstract][Full Text] [Related]
25. Quantitative screening for anticestode drugs based on changes in baseline enzyme secretion by Taenia crassiceps.
Mahanty S; Madrid EM; Nash TE
Antimicrob Agents Chemother; 2013 Feb; 57(2):990-5. PubMed ID: 23229489
[TBL] [Abstract][Full Text] [Related]
26. Partial inhibition of the main energetic pathways and its metabolic consequences after
Picanço GA; de Lima NF; Gomes TC; Fraga CM; Alves DSMM; Castillo R; da Costa TL; Lino-Junior RS; Ambrosio J; Vinaud MC
Parasitology; 2019 Oct; 146(12):1578-1582. PubMed ID: 31303189
[TBL] [Abstract][Full Text] [Related]
27. Experimental encephalitis caused by Taenia crassiceps cysticerci in mice.
Matos-Silva H; Reciputti BP; Paula EC; Oliveira AL; Moura VB; Vinaud MC; Oliveira MA; Lino-Júnior Rde S
Arq Neuropsiquiatr; 2012 Apr; 70(4):287-92. PubMed ID: 22358311
[TBL] [Abstract][Full Text] [Related]
28. Demyelination in experimental intraventricular neurocysticercosis.
Moura VBL; Milhomem AC; Lima SB; Matos-Silva H; Sugita DM; Vinaud MC; Lino-Júnior RS
Arq Neuropsiquiatr; 2020 Feb; 78(2):103-111. PubMed ID: 32022135
[TBL] [Abstract][Full Text] [Related]
29. Two novel ternary albendazole-cyclodextrin-polymer systems: dissolution, bioavailability and efficacy against Taenia crassiceps cysts.
Palomares-Alonso F; González CR; Bernad-Bernad MJ; Montiel MD; Hernández GP; González-Hernández I; Castro-Torres N; Estrada EP; Jung-Cook H
Acta Trop; 2010 Jan; 113(1):56-60. PubMed ID: 19769931
[TBL] [Abstract][Full Text] [Related]
30. Do albendazole-loaded lipid nanocapsules enhance the bioavailability of albendazole in the brain of healthy mice?
Fabbri J; Espinosa JP; Pensel PE; Medici SK; Gamboa GU; Benoit JP; Elissondo MC
Acta Trop; 2020 Jan; 201():105215. PubMed ID: 31600525
[TBL] [Abstract][Full Text] [Related]
31. Cellular immune response in intraventricular experimental neurocysticercosis.
Moura VB; Lima SB; Matos-Silva H; Vinaud MC; Loyola PR; Lino RS
Parasitology; 2016 Mar; 143(3):334-42. PubMed ID: 26626017
[TBL] [Abstract][Full Text] [Related]
32. Anthelmintics for people with neurocysticercosis.
Monk EJM; Abba K; Ranganathan LN
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD000215. PubMed ID: 34060667
[TBL] [Abstract][Full Text] [Related]
33. In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against Taenia solium.
Paredes A; de Campos Lourenço T; Marzal M; Rivera A; Dorny P; Mahanty S; Guerra-Giraldez C; García HH; Nash TE; Cass QB;
Antimicrob Agents Chemother; 2013 Feb; 57(2):944-9. PubMed ID: 23229490
[TBL] [Abstract][Full Text] [Related]
34. In vitro effect of praziquantel and albendazole combination therapy on the larval stage of Echinococcus granulosus.
Urrea-París MA; Moreno MJ; Casado N; Rodriguez-Caabeiro F
Parasitol Res; 2000 Dec; 86(12):957-64. PubMed ID: 11133110
[TBL] [Abstract][Full Text] [Related]
35. Histopathologic aspects of experimental cysticercosis and in situ cytokines profile in C57BL/6 mice.
Milhomem AC; Souza AJS; Silva HM; Vinaud MC; Oliveira MAP; Machado JR; Lino Júnior RS
Arq Neuropsiquiatr; 2018 May; 76(5):339-345. PubMed ID: 29898081
[TBL] [Abstract][Full Text] [Related]
36. Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.
Ceballos L; Elissondo C; Sánchez Bruni S; Denegri G; Lanusse C; Alvarez L
Antimicrob Agents Chemother; 2011 Dec; 55(12):5861-7. PubMed ID: 21930885
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
Garcia HH; Lescano AG; Lanchote VL; Pretell EJ; Gonzales I; Bustos JA; Takayanagui OM; Bonato PS; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
Br J Clin Pharmacol; 2011 Jul; 72(1):77-84. PubMed ID: 21332573
[TBL] [Abstract][Full Text] [Related]
38. Combined flubendazole-nitazoxanide treatment of cystic echinococcosis: Pharmacokinetic and efficacy assessment in mice.
Laura C; Celina E; Sergio SB; Guillermo D; Carlos L; Luis A
Acta Trop; 2015 Aug; 148():89-96. PubMed ID: 25917712
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of albendazole against Taenia multiceps larvae in experimentally infected goats.
Afonso SM; Neves L; Pondja A; Macuamule C; Mukaratirwa S; Arboix M; Cristòfol C; Capece BP
Vet Parasitol; 2014 Dec; 206(3-4):304-7. PubMed ID: 25450723
[TBL] [Abstract][Full Text] [Related]
40. Sodium arsenite augments sensitivity of Echinococcus granulosus protoscoleces to albendazole.
Xing G; Zhang H; Liu C; Guo Z; Yang X; Wang Z; Wang B; Lei Y; Yang R; Jiang Y; Lv H
Exp Parasitol; 2019 May; 200():55-60. PubMed ID: 30790573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
